The deals cover development and commercialization of next-generation sequencing and digital PCR assays for minimal residual disease detection.

Northwestern Medical will begin using PathAI's AISight digital pathology image management system as part of the deal.

Northwestern Medical will begin using PathAI's AISight digital pathology image management system as part of the deal.

The BLIPI test device was used to monitor babies' immune status from a drop of whole blood and detected sepsis within 15 minutes, enabling incubator-side testing.

Last week, readers were most interested in a story about what's up Roche's sleeve as it talked about its plans during its investor day.

Of the 30 companies included in the list, 15 saw their stock prices decline, while 15 saw their share prices rise.

The RiskReveal assay was used to determine which early-stage non-squamous NSCLC patients should undergo adjuvant chemotherapy.

Investors and consultants in the space said that they have seen rising enthusiasm among investors as recent funding rounds ...

NEW YORK – Cizzle Bio, a London-based provider of blood tests for the early detection of lung and gastric cancers, this week inked an agreement with Doctors Hospital in the Cayman Islands to provide ...

The firm touted new assays, provided an update on its nanopore sequencer, and offered insights into upcoming pipeline ...

NEW YORK – OncoHost, an Israeli biotechnology company, is working with three European medical centers to produce a new flow cytometry test to predict patient response to immunotherapies for five ...

NEW YORK — Genedrive said Friday that it has received CE marking under the EU's In Vitro Diagnostic Medical Device Regulation (IVDR) for its point-of-care CYP2C19 ID Kit genotyping platform, which is ...